Print RSS
Eastland Medical Systems Ltd

Eastland Medical Systems is a publicly listed Company on the Australian Securities Exchange (ASX:EMS) that is involved in the commercialisation of low-risk pharmaceutical projects.

The Company's key project is ArTiMist™, a malaria treatment developed specifically for children with severe malaria.
Announcements News & Media Releases
1.    11-09-29 ArTiMist™ listed as one of the 5 most promising drugs in Phase III trials  11-09-29 ArTiMist™ listed as one of the 5 most promising drugs in Phase III trials (11 KB)
2.    11-09-23 Eastland Raises $226,000 on Priority Entitlement Offer  11-09-23 Eastland Raises $226,000 on Priority Entitlement Offer (68 KB)
3.    11-07-11 Boardroom Radio Broadcast  11-07-11 Boardroom Radio Broadcast (76 KB)
4.    11-07-06 SHAREHOLDER UPDATE - JULY 2011  11-07-06 SHAREHOLDER UPDATE - JULY 2011 (95 KB)
5.    11-05-31 The Lancet article "From quinine to artesunate in Africa"  11-05-31 The Lancet article "From quinine to artesunate in Africa" (281 KB)
6.    11-05-31 Eastland Clinical Trial Update May 2011  11-05-31 Eastland Clinical Trial Update May 2011 (129 KB)
7.    11-04-28 Clinical Trial Update  11-04-28 Clinical Trial Update (150 KB)
8.    11-04-12 Eastland raises $4.2 Milion on Placement & Share Purchase Plan  11-04-12 Eastland raises $4.2 Milion on Placement & Share Purchase Plan (155 KB)
9.    11-04-06 AFR article April 5, 2011  11-04-06 AFR article April 5, 2011 (3335 KB)
10.    11-04-05 Update on Eastland's subsidiary Westcoast Surgical & Medical Supplies  11-04-05 Update on Eastland's subsidiary Westcoast Surgical & Medical Supplies (214 KB)
11.    11-03-29 EMS Presentation  11-03-29 EMS Presentation (3608 KB)
12.    11-03-28 SPP EXTENSION  11-03-28 SPP EXTENSION (69 KB)
13.    11-03-17 BOARDROOM RADIO BROADCAST  11-03-17 BOARDROOM RADIO BROADCAST (145 KB)
14.    11-03-08 Share purchase Plan Offer  11-03-08 Share purchase Plan Offer (841 KB)
15.    11-03-03 UPDATE  11-03-03 UPDATE (234 KB)
16.    11-03-01 Half Yearly Report and Accounts  11-03-01 Half Yearly Report and Accounts (1565 KB)
17.    11-02-02 Eastland’s subsidiary wins first tender valued at $2.5m  11-02-02 Eastland’s subsidiary wins first tender valued at $2.5m (586 KB)
18.    11-02-01 Change of Director`s Interest Notice  11-02-01 Change of Director`s Interest Notice (171 KB)
19.    11-01-10 Westcoast Surgical and Medical Supplies  11-01-10 Westcoast Surgical and Medical Supplies (589 KB)
20.    11-01-04 Director's clarification on share sale  11-01-04 Director's clarification on share sale (578 KB)
21.    10-11-25 Patient study findings are very positive for ARTIMIST  10-11-25 Patient study findings are very positive for ARTIMIST (608 KB)
22.    10-11-18 Response to ASX query  10-11-18 Response to ASX query (77 KB)
23.    10-11-23 MALARIA TRIAL - PATIENT DOSING COMMENCED  10-11-23 MALARIA TRIAL - PATIENT DOSING COMMENCED (598 KB)
24.    10-10-28 Notice of Annual General Meeting  10-10-28 Notice of Annual General Meeting (172 KB)
25.    10-10-27 Management and Board Restructure  10-10-27 Management and Board Restructure (567 KB)
26.    10-09-30 Eastland accepts unconditional offer for its Portand property  10-09-30 Eastland accepts unconditional offer for its Portand property (556 KB)
27.    10-09-21 Clinican Trial Results Presented at ICAAC in Boston USA  10-09-21 Clinican Trial Results Presented at ICAAC in Boston USA (3091 KB)
28.    10-08-09 SUCCESSFUL PLACEMENT  10-08-09 SUCCESSFUL PLACEMENT (555 KB)
29.    10-07-09 CALVIN ROSS  10-07-09 CALVIN ROSS (890 KB)
30.    10-07-22 BOARDROOM INTERVIEW  10-07-22 BOARDROOM INTERVIEW (554 KB)
31.    10-07-21 Consultant Appointment  10-07-21 Consultant Appointment (560 KB)
32.    10-07-06 Response to ASX Query  10-07-06 Response to ASX Query (2696 KB)
33.    10-07-05 Eastland to present at the 2010 Interscience Conference  10-07-05 Eastland to present at the 2010 Interscience Conference (600 KB)
34.    10-06-11 Event Impact - Industrial Research  10-06-11 Event Impact - Industrial Research (529 KB)
35.    10-06-11 ASX Release - Update on HC Berlin Pharna AG and Clinical Trials  10-06-11 ASX Release - Update on HC Berlin Pharna AG and Clinical Trials (609 KB)
36.    10-05-19 ASX Release No 454 Research Report - ArtiMist  10-05-19 ASX Release No 454 Research Report - ArtiMist (755 KB)
37.    10-04-28 New Treatment to Reduce Deaths in Children with Malaria  10-04-28 New Treatment to Reduce Deaths in Children with Malaria (605 KB)
38.    10-04-28 ArTiMist™ Study Highly Successfull in Treating Children With Severe Malaria  10-04-28 ArTiMist™ Study Highly Successfull in Treating Children With Severe Malaria (623 KB)
more>>
Broker Research
1.    11-03-08 Event impact Patersons  11-03-08 Event impact Patersons (453 KB)
2.    11-03-04 Event Impact Patersons  11-03-04 Event Impact Patersons (442 KB)
3.    10-11-26 Significant implications for ArTiMist from IV Artesunate trial. SPEC BUY  10-11-26 Significant implications for ArTiMist from IV Artesunate trial. SPEC BUY (433 KB)
4.    10-10-28 Event Impact - Patersons  10-10-28 Event Impact - Patersons (384 KB)
5.    10-08-09 UPDATE RESEARCH REPORT  10-08-09 UPDATE RESEARCH REPORT (431 KB)
6.    10-07-06 Event Impact - Patersons Securities  10-07-06 Event Impact - Patersons Securities (548 KB)
7.    10-06-11 Event Impact - Industrial Research  10-06-11 Event Impact - Industrial Research (529 KB)
8.    10-05-19 ArtiMist - The Next Front-Line Drug for Severe Malaria  10-05-19 ArtiMist - The Next Front-Line Drug for Severe Malaria (585 KB)
9.    10-04-29 Event Impact - Industrial Research  10-04-29 Event Impact - Industrial Research (523 KB)
more>>
Roll Back Malaria


Malaria in the News